Succesful treatment with Foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndromeCHATIS, P. A; MILLER, C. H; SCHRAGER, L. E et al.The New England journal of medicine. 1989, Vol 320, Num 5, pp 297-300, issn 0028-4793, 4 p.Article

Simultaneous treatments of cytomegalovirus retinitis with ganciclovir and foscarnetNELSON, M. R; BARTER, G; HAWKINS, D et al.Lancet (British edition). 1991, Vol 338, Num 8761, issn 0140-6736, p. 250Article

Antiviral chemotherapy for cytomegalovirus diseaseMORRIS, D. J.Journal of antimicrobial chemotherapy (Print). 1988, Vol 21, Num 5, pp 519-522, issn 0305-7453Article

Inhibition of HTLV-III/LAV replication by foscarnetSARIN, P. S; TAGUCHI, Y; SUN, D et al.Biochemical pharmacology. 1985, Vol 34, Num 22, pp 4075-4079, issn 0006-2952Article

PENILE EROSIONS ASSOCIATED WITH FOSCARNET THERAPY IN A CHILDHICK, Ryan W; PROSE, Neil.Pediatric dermatology. 2010, Vol 27, Num 3, pp 302-303, issn 0736-8046, 2 p.Article

Age-related differences in pharmacokinetics of phosphonoformate in catsSWENSON, C. L; SAMS, R. A; POLAS, P. J et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 5, pp 871-874, issn 0066-4804Article

Les antiviraux = Antiviral agentsLEPORT, C; VILDE, J.-L.Réanimation, soins intensifs, médecine d'urgence. 1989, Vol 5, Num 6, pp 361-367, issn 0765-5290Article

Stability of foscarnet sodium in 0.9 % sodium chloride injectionWOODS, K; STEINMANN, W; BRUNS, L et al.AJHP. American journal of hospital pharmacy. 1994, Vol 51, Num 1, pp 88-90Article

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitroMANISCHEWITZ, J. F; QUINNAN, G. V. JR; CLIFFORD LANE, H et al.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 2, pp 373-375, issn 0066-4804Article

Determination of phosphonoformate (foscarnet) in biological fluids by ion-pair reversed-phase liquid chromatographyPETTERSSON, K.-J; NORDGREN, T; WESTERLUND, D et al.Journal of chromatography. 1989, Vol 488, Num 2, pp 447-455, issn 0021-9673Article

Aspects of viral chemotherapySHUGAR, D.Pharmacology & therapeutics (Oxford). 1989, Vol 40, Num 2, pp 171-328, issn 0163-7258Serial Issue

Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDSFARTHING, C; ANDERSON, M. G; ELLIS, M. E et al.Journal of medical virology. 1987, Vol 22, Num 2, pp 157-162, issn 0146-6615Article

Neurologic sequelae associated with foscarnet therapyLOR, E; YONG QING LIU.The Annals of pharmacotherapy. 1994, Vol 28, Num 9, pp 1035-1037, issn 1060-0280Article

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipientsASCHAN, J; RINGDEN, O; LJUNGMAN, P et al.Scandinavian journal of infectious diseases. 1992, Vol 24, Num 2, pp 143-150, issn 0036-5548Article

Effect of foscarnet therapy on infection with human immunodeficiency virus in patients with AIDSJACOBSON, M. A; CROWE, S; LEVY, J et al.The Journal of infectious diseases. 1988, Vol 158, Num 4, pp 862-865, issn 0022-1899Article

Treatment of cytomegalovirus retinitis - 1992JABS, D. A.Archives of ophthalmology (1960). 1992, Vol 110, Num 2, pp 185-187, issn 0003-9950Article

Development of antiviral agents for the treatment of human immunodeficiency virus injectionTARTAGLIONE, T. A; COLLIER, A. C.Clinical pharmacy. 1987, Vol 6, Num 12, pp 927-940, issn 0278-2677Article

Successful treatment with trisodium phosphonoformate for primary cytomegalovirus infection after heart transplantationLOCKE, T. J; ODOM, N. J; TAPSON, J. S et al.The Journal of heart transplantation. 1987, Vol 6, Num 2, pp 120-122, issn 0887-2570Article

Age-related differences in phosphonoformate-induced bone toxicity in catsSWENSON, C. L; WEISBRODE, S. E; NAGODE, L. A et al.Calcified tissue international. 1991, Vol 48, Num 5, pp 353-361, issn 0171-967X, 9 p.Article

Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detectionHASSANZADEH, M. K; AWEEKA, F. T; WU, S et al.Journal of chromatography. Biomedical applications. 1990, Vol 525, Num 1, pp 133-140, issn 0378-4347Article

The future of antiviral chemotherapyCROWE, S; MILLS, J.Dermatologic clinics. 1988, Vol 6, Num 4, pp 521-537, issn 0733-8635Article

Stability of foscarnet sodium in 5% dextrose and 0.9% sodium chloride injectionsMATHEW, M; DAS GUPTA, V; BETHEA, C et al.Journal of clinical pharmacy and therapeutics (Print). 1994, Vol 19, Num 1, pp 35-36, issn 0269-4727Article

Myélo-méningo-radiculite, secondaire à une infection à CMV chez un sujet non immunodéprimé : traitement par foscarnet = Foscarnet treatment of myelomeningoradiculitis secondary to cytomegalovirus infection in a non-immunodepressed subjectROGEAUX, O; BEDOS, J. P; WOLF, M et al.Annales de médecine interne (Paris). 1992, Vol 143, Num 3, pp 219-220, issn 0003-410XArticle

Crystallization After Intravitreous Foscarnet InjectionsMARTINEZ-CASTILLO, Sebastián; MARIN-LAMBIES, Cristina; GALLEGO-PINAZO, Roberto et al.Archives of ophthalmology (1960). 2012, Vol 130, Num 5, pp 658-659, issn 0003-9950, 2 p.Article

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblastsNAESENS, Lieve; BONNAFOUS, Pascale; AGUT, Henri et al.Journal of clinical virology. 2006, Vol 37, issn 1386-6532, S69-S75, SUP1Conference Paper